honokiol has been researched along with Retinal Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mukherji, M; O'Bryhim, BE; Ponnaluri, VK; Radel, J; Symons, RC; Vavilala, DT; White, RS | 1 |
| Mukherji, M; Subhani, S; Vavilala, DT | 1 |
1 review(s) available for honokiol and Retinal Neovascularization
| Article | Year |
|---|---|
HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Anthracyclines; Biphenyl Compounds; Cardiac Glycosides; Humans; Hypoxia-Inducible Factor 1; Indazoles; Lignans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Retinal Neovascularization; Vascular Endothelial Growth Factors | 2016 |
1 other study(ies) available for honokiol and Retinal Neovascularization
| Article | Year |
|---|---|
Honokiol inhibits pathological retinal neovascularization in oxygen-induced retinopathy mouse model.
Topics: Animals; Antibiotics, Antineoplastic; Biphenyl Compounds; Cell Line; Digoxin; Doxorubicin; Drugs, Chinese Herbal; Enzyme Inhibitors; Humans; Hypoxia-Inducible Factor 1; Lignans; Mice; Mice, Inbred C57BL; Oxygen; Retina; Retinal Neovascularization; Transcriptional Activation | 2013 |